Vanda Pharma
VNDA----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Vanda Pharma(VNDA) predict that the Revenue is 51.72 M (+3.35%), Miss estimate;the EBIT is -50.22 M (-22.41%), Beat estimate;the EPS is -0.82 (-64%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.05B3.35%
0.05B5.71%
-0.00B2.36%
EBITExceed expectations
-0.05B22.41%
-0.05B28.33%
+0.00B5.92%
EPSMiss expectations
-0.8264.00%
-0.687537.50%
-0.132526.50%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf